Home » Topics » BioWorld Science

BioWorld Science
RSS

Medshine Discovery presents KRAS mutant inhibitors

Aug. 1, 2019

Sage Therapeutics identifies new GABA-A receptor modulators

Aug. 1, 2019

Kymera Therapeutics patents CRBN inhibitors

Aug. 1, 2019

Researchers investigate dose optimization for levornidazole

Aug. 1, 2019

Developmental biliary agenesis in ALGS is reversible via restoration of Jagged/Notch

Aug. 1, 2019

Jaktinib demonstrates promising safety and PK in healthy volunteers

Aug. 1, 2019

Turning Point Therapeutics initiates phase I clinical study of TPX-0022

Aug. 1, 2019

FDA grants approval for new monotherapy indication for Keytruda

Aug. 1, 2019

CARB-X funds BB100 to develop a unique monoclonal antibody against E. coli infection

Aug. 1, 2019

PSLNR, an androgen-receptor prostate-specific lncRNA, is involved in prostate cancer progression

Aug. 1, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...